Area of research
Cardiology and Cardiovascular Medicine · Internal Medicine
Research interest
Research interests include Antiplatelet Therapy and Cardiovascular Diseases, Atrial Fibrillation Management and Outcomes, Venous Thromboembolism Diagnosis and Management, and Acute Myocardial Infarction Research.
Influence of Intensive Lipid-Lowering With Statin and Ezetimibe Prescription on Computed Tomography–Derived Fractional Flow Reserve in Patients With Stable Chest Pain
Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks.
Obstructive sleep apnoea is associated with accelerated progression of diabetic kidney disease.
Cardiovascular pharmacotherapy in 2025.
Coronary plaque burden as a determinant of cardiovascular outcomes in patients undergoing percutaneous coronary intervention versus coronary artery bypass grafting: The Western Denmark Heart Registry.
Psychometric properties of patient-related outcome measures used for patients surviving a pulmonary embolism: A systematic review.
Effects of Acute Exercise and 12-Week High-Intensity Interval Training on Inflammatory Biomarkers in Stable Coronary Artery Disease: A Randomized Controlled Trial.
Cyclooxygenase-1-inhibition with aspirin in patients with chronic coronary syndrome
Bleeding risk using non-steroidal anti-inflammatory drugs with anticoagulants after venous thromboembolism: a nationwide Danish study.
Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart).
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2024.
<i>European Journal of Heart Failure</i> Consensus Statement. Heart Failure Pharmacotherapy for Patients with Heart Failure with Reduced Ejection Fraction and Concomitant Atrial Fibrillation: Review of Evidence and Call to Action
Antithrombotic therapy in patients with atrial high-rate episodes (AHREs): Current evidence and open questions.
Genotype-guided de-escalation and abbreviation of dual antiplatelet therapy in patients with myocardial infarction and high bleeding risk: Design and rationale of the investigator-initiated, multicenter, randomized, controlled trial, DAN-DAPT.
General practice-related variation in oral anticoagulant treatment of atrial fibrillation: a nationwide cohort study.
Temporal trends and patient determinants of geographical variation in oral anticoagulant treatment of atrial fibrillation: a Danish nationwide cohort study in 2013-2022.
Enhanced recovery and abbreviated length of anticoagulation for thromboprophylaxis after primary hip arthroplasty rationale and design of the ENABLE-hip trial.
Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use: A Subgroup Analysis of the OCEANIC-AF Randomized Clinical Trial.
Cardiovascular autonomic dysfunction precedes cardiovascular disease and all-cause mortality: 11-year follow-up in the ADDITION-PRO study.
Direct oral anticoagulant failure in patients with venous thromboembolism-why and what next?
Changes in platelet maturity and reactivity following acute ST-segment elevation myocardial infarction.
Good FFR<sub>CT</sub> Test-Retest Reproducibility: The Importance of High Coronary CT Angiography Image Quality.
Edema and Outcome in Patients with Nephrotic-Range Albuminuria and Hypoalbuminemia: A Danish Multicenter Cohort Study.
European Journal of Heart Failure consensus statement. Heart failure pharmacotherapy for patients with heart failure with reduced ejection fraction and concomitant atrial fibrillation: Review of evidence and call to action.
Coronary CT angiography instead of invasive angiography before TAVI: Feasibility and outcomes.
Recurrent ischemic stroke/transient ischemic attack after patent foramen ovale closure: A cohort study.
MicroRNA dynamics and their link to platelet function following acute ST-segment elevation myocardial infarction.
Development of a questionnaire investigating the physical and psychological well-being and need for rehabilitative strategies in patients with pulmonary embolism.
When more is worse: aspirin backfires in anticoagulated post-PCI patients.
Impact of shifting from routine use of ticagrelor to prasugrel in myocardial infarction patients after PCI: a nationwide cohort study.